Importantly, P2Y12-R constitutive signaling needs to be fine-tuned to ensure proper control of hemostasis since loss of P2Y12-R constitutive activity was associated with bleeding syndrome [17] while enhanced P2Y12-R constitutive signaling was correlated with platelet hyperactivity in diabetes [18]. Here, P2RY12 is linked to diabetes mellitus.